Meta-analysis of seven randomized control trials to assess the efficacy and toxicity of combining EGFR-TKI with chemotherapy for patients with advanced NSCLC who failed first-line treatment.
- DOI
- 10.7314/apjcp.2015.16.7.2915
- Published
- 2015-01-01
- Container
- Asian Pac J Cancer Prev
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7314/apjcp.2015.16.7.2915,
title = {Meta-analysis of seven randomized control trials to assess the efficacy and toxicity of combining EGFR-TKI with chemotherapy for patients with advanced NSCLC who failed first-line treatment.},
author = {Xiao BK and Yang JY and Dong JX and Ji ZS and Si HY and Wang WL and Huang RQ.},
year = {2015},
journal = {Asian Pac J Cancer Prev},
doi = {10.7314/apjcp.2015.16.7.2915},
url = {https://doi.org/10.7314/apjcp.2015.16.7.2915}
}RIS
TY - JOUR TI - Meta-analysis of seven randomized control trials to assess the efficacy and toxicity of combining EGFR-TKI with chemotherapy for patients with advanced NSCLC who failed first-line treatment. AU - Xiao BK AU - Yang JY AU - Dong JX AU - Ji ZS AU - Si HY AU - Wang WL AU - Huang RQ. PY - 2015 JO - Asian Pac J Cancer Prev DO - 10.7314/apjcp.2015.16.7.2915 UR - https://doi.org/10.7314/apjcp.2015.16.7.2915 ER -
APA
BK, X., JY, Y., JX, D., ZS, J., HY, S., WL, W., & RQ., H. (2015). Meta-analysis of seven randomized control trials to assess the efficacy and toxicity of combining EGFR-TKI with chemotherapy for patients with advanced NSCLC who failed first-line treatment.. Asian Pac J Cancer Prev. https://doi.org/10.7314/apjcp.2015.16.7.2915
Source records
- europe-pmc · retrieved 2026-09-26T23:33:28.259Z